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Germline mutation of the tumor suppressor gene CDC73 confers susceptibility to the hyperparathyroidism-jaw tumor syndrome
associated with a high risk of parathyroid malignancy. Inactivating CDC73 mutations have also been implicated in sporadic
parathyroid cancer, but are rare in sporadicbenign parathyroidtumors.The molecularpathways that distinguishmalignant from
benign parathyroid transformation remain elusive. We previously showed that a hypomorphic allele of hyrax (hyx), the
Drosophila homolog of CDC73, rescues the loss-of-ventral-eye phenotype of lobe, encoding the ﬂy homolog of Akt1s1/ PRAS40.
We report now an interaction between hyx and Tor, a central regulator of cell growth and autophagy, and show that eukaryotic
translation initiation factor 4E-binding protein (EIF4EBP), a translational repressor and effector of mammalian target of
rapamycin (mTOR), is a conserved target of hyx/CDC73. Flies heterozygous for Tor and hyx, but not Mnn1, the homolog of the
multiple endocrine neoplasia type 1 (MEN1) tumor suppressor associated with benign parathyroid tumors, are starvation
resistant with reduced basal levels of Thor/4E-BP. Human peripheral blood cell levels of EIF4EBP3 were reduced in patients with
CDC73, but not MEN1, heterozygosity. Chromatin immunoprecipitation demonstrated occupancy of EIF4EBP3 by endogenous
paraﬁbromin. These results show that EIF4EBP3 is a peripheral marker of CDC73 function distinct from MEN1-regulated
pathways, and suggest a model whereby starvation resistance and/or translational de-repression contributes to parathyroid
malignant transformation.
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Germline loss-of-function mutation of the tumor suppressor
gene CDC73 (also known as HRPT2) confers susceptibility to
the hyperparathyroidism-jaw tumor syndrome (HPT-JT), an
autosomal dominant familial cancer syndrome associated
with a high risk of parathyroid malignancy.
1–6 Analysis of
multiple kindreds with HPT–JT by Carpten et al.
7 led to the
identiﬁcation of CDC73/HRPT2 by positional candidate
cloning. Inactivating somatic and/or germline CDC73/HRPT2
mutations have also been implicated in sporadic parathyroid
cancer.
8,9 CDC73 encodes paraﬁbromin,
7 a 531-amino acid
putative tumor suppressor protein with sequence homology to
yeast Cdc73p.
10 As was originally shown in yeast for
Cdc73p,
11 evidence in humans suggests that paraﬁbromin
interacts with RNA polymerase II as a part of the PAF1
complex.
12–14 The components of the PAF1 complex are
highlyconservedin Drosophilaaswell, including hyrax(hyx)a
homolog of CDC73.
15
Despite its strong association with parathyroid cancer,
inactivation of CDC73 is quite rare in sporadic, benign
parathyroid tumors.
16,17 In contrast, inactivation of the multi-
ple endocrine neoplasia type 1 (MEN1) tumor suppressor
gene is nearly always associated with benign parathyroid
tumors in the context of familial or sporadic MEN1,
18 and
somatic inactivation of MEN1 in sporadic benign parathyroid
tumors is common.
19,20 Despite the identiﬁcation of these key
parathyroid tumor suppressor genes, the mechanisms and
pathways that distinguish benign from malignant transforma-
tion of the parathyroid remain elusive. Furthermore, the
development of a Cdc73/Hrpt2 knockout mouse model
21
and other experimental approaches
15,22,23 have sofaryielded
little insight into the pathway(s) whereby CDC73 loss-of-
function might promote tumorigenesis.
Using Drosophila as a model system, we recently showed
that hyx mutant ﬂies were resistant to starvation and that hyx
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www.nature.com/cddisrescued the loss-of-ventral-eye phenotype of lobe, the ﬂy
homolog of Akt1 substrate 1 (AKT1S1).
24 Akts1, also
called 40kDa proline-rich AKT substrate (PRAS40), is a
negativeregulator of mammaliantarget ofrapamycin (mTOR)
complex 1.
25 The protein kinase mTOR functions as a cellular
sensor of nutrient and energy availability, and regulates cell
growth and autophagy.
26
One well-characterized effector of mTOR is the eukaryotic
translation initiation factor 4E-binding protein (eIF4EBP or
4E-BP) that competes with eIF-4G for binding to eIF-4E to
inhibit mRNA cap-dependent translational initiation.
27,28
Phosphorylation of eIF4EBP by mTOR reduces its afﬁnity
foreIF-4Eandpromotestheinitiationofproteinsynthesisfrom
a pool of transcripts enriched in mRNAs encoding proteins
involved in angiogenesis, growth, and survival.
29 Enhanced
function of eIF-4E, often a result of inactivation of eIF4EBP
by phosphorylation, is linked to poor prognosis, tumor
progression, and metastasis in squamous cell,
30 breast,
31,32
ovarian,
33 and other cancers.
We demonstrate now that EIF4EBP is an evolutionarily
conserved target of hyx/CDC73, and show that basal and
serumstarvation-stimulatedlevelsofEIF4EBP3transcriptare
reduced in peripheral mononuclear cells from patients
heterozygous for CDC73, but not MEN1. We show that the
expression of the EIF4EBP3 translational repressor repre-
sents a peripheral marker of CDC73 function and propose a
modelwherebystarvationresistance,mediatedatleastinpart
by de-repression of protein translation, may contribute to
parathyroid malignant transformation.
Results
WepreviouslyshowedthatinDrosophilaahypomorphicallele
of hyx rescues the eye phenotype of lobe and that
hyx heterozygous ﬂies were resistant to starvation.
24 Thus,
L
si/þ; hyx
EY6898/þ double heterozygotes have normal eyes,
even though heterozygous L
si/þ ﬂies show a loss-of-ventral-
eye phenotype (Figure 1e, cf. 1a–c), and provide a sensitive
genetic background to identify additional genes that interact
with L, hyx, or both by eye phenotype screening.
24
On the basis of the rescue of lobe by hyx and the enhanced
resistance to starvation seen in hyx heterozygous ﬂies,
24 we
used the eye phenotype screening assay to look for an
interaction of hyx with Tor, a key regulator of cellular nutritional
homeostasis
26 and target of lobe/ Akt1S1/ PRAS40
inhibition.
25 To this end we crossed doubly heterozygous
(L
si/þ;h y x
EY6898/þ)ﬂ i e sw i t haTor
MB07988 mutant strain
(Figures 1h–q, s, and t; Table 1). Approximately, 40% of the
tripleheterozygote(L
si/Tor
MB07988hyx
EY6898/þ)ﬂieshadNOG
eye phenotypes (notch and dysplastic overgrowth), including
halfeyeswithdysplasticovergrowths
24(Figures1h–k;Table1,
cross 8). The overgrowths typically appeared in or near the
missing ventral eye region (Figures 1i–q). The ommatidia and
the sensory bristles were deformed and in disarray (Figures 1s
and t, cf. 1r). Testing of another Tor mutant allele, Tor
K17004,
gave similar results (Table 1, cross 10). In contrast, 90% or
more of the doubly heterozygous mutant ﬂies carrying the L
si
allele (L
si/Tor
MB07988L
si/Tor
K17004 L
si/þ;hyx
EY6898/þ)h a d
normal eyes (Figures 1e and f; Table 1, crosses 3, 7, and
11). As the other possible doubly heterozygous mutant
combinations from the same matings produced ﬂies with
normal eyes (Figure 1g; Table 1, crosses 9 and 12), the
observed strong eye phenotype must result from the speciﬁc
combination of hyx and Tor loss-of-function.
We previously showed that the eye discs of L
si/þ;
hyx
EY6898/orb2
BG02373 triple heterozygotes with a propensity
tolater develop the NOGphenotype were characterized by an
abnormal pattern of apoptosis at the larval stage.
24 In
contrast, the larval eye discs of L
si/Tor
MB07988 hyx
EY6898/þ
triple heterozygotes showed no gross abnormalities in the
pattern or extent of apoptosis compared with w
1118 controls
(data not shown).
We, therefore, compared the pupal eye discs of wild-type
and L
si/Tor
MB07988 hyx
EY6898/þ triple heterozygotes to look
for developmental abnormalities that might account for the
subsequent development of the NOG phenotype in the triple
mutants. Normal eye development in Drosophila involves a
waveofcellapoptosisbetween35and50hafterpupationthat
eliminates a large fraction of undifferentiated interommatidial
cells.
34 The pupal eye discs of wild-type and L
si/Tor
MB07988
hyx
EY6898/þ triple heterozygote ﬂies were, therefore, exam-
ined at 45h after pupation using the terminal deoxynucleotidyl
transferase mediated dUTP nick end labeling (TUNEL) assay
to identify the nuclei of cells undergoing apoptosis (Figure 2).
EyediscsfromL
si/Tor
MB07988hyx
EY6898/þ tripleheterozygote
pupae showed a disordered pattern of apoptosis as well as a
signiﬁcant decrease in TUNEL-positive apoptotic nuclei
compared with eyes from w
1118 controls (Figures 2a and b).
Thus, the eye discs of L
si/Tor
MB07988 hyx
EY6898/þ triple
heterozygotes with a propensity to later develop the NOG
phenotype were characterized by a substantial reduction in
the usual burst of apoptosis between 35 and 50h after
pupation.
As current models suggest that Tor acts as a nutrient
sensor, and regulator of cell growth and autophagy,
26 we
studied starvation resistance in Tor and hyx mutant ﬂies.
Consistent with our previous results,
24 hyx heterozygous ﬂies
were resistant to starvation compared with w
1118 controls
(Figure 3a). Resistance to starvation was also found to be
higher in Tor (Tor
MB07988/þ) heterozygous ﬂies (Figure 3b).
Double hyx/ Tor heterozygotes (Tor
MB07988/þ; hyx
EY6898/þ)
were also resistant to starvation without any obvious additivity
of the effect (Figure 3c).
A separate set of experiments used a different mutant allele
of Tor (Tor
K17004) and showed that Tor
K17004/þ heterozy-
gotes, like Tor
MB07988/þ heterozygous ﬂies, exhibited resis-
tance to starvation (Figure 3d). A double hyx/ Tor
heterozygote strain demonstrated comparable resistance to
starvation as seen with the single heterozygotes (Figure 3e,
cf. 3a and d). We tested for rescue of the phenotype exploiting
the fact that hyx can be overexpressed in strains carrying the
GAL4-sensitive hyx
EY6898 allele by mating to GAL4-over-
expressingstrains.
15,24AsshowninFigure3f,overexpression
of hyx in ﬂies carrying the ubiquitously expressed act5C-Gal4
driver and doubly heterozygous for hyx/ Tor mutation restored
starvation sensitivity to near control levels, whereas control
ﬂies with 5C-actin promoter-driven GAL4 expression only had
slightlyenhanced starvationresistance (Figure 3f). Incontrast
to the hyx mutants, ﬂies heterozygous for Mnn1
(Mnn1
DG30701/þ) were sensitive to starvation like the w
1118
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Cell Death and Diseasecontrols (Figure 3g). Thus, heterozygosity of hyx and Tor, but
not Mnn1, confers starvation resistance. Furthermore, hyx
gene overexpression, at least at time points o100h in a
model system using the GAL4-sensitive hyx
EY6898 allele and
the act5C-Gal4 driver, can rescue the starvation-resistant
phenotype of Tor.
To better understand the interaction between hyx and Tor,
quantitative RT-PCR was used to measure transcript levels in
hyx or Tor mutant ﬂy strains. Levels of hyx transcript were
partially reduced in Tor
MB07988 heterozygotes and by some
30% in Tor
MB07988 homozygotes compared to with control
(Figure 4a). In contrast, adult ﬂies heterozygous for hyx
EY6898
TorMB07988/ MB07988 Lsi/+
Lsi/TorMB07988
w1118 hyxEY6898/+
TorMB07988/+;hyxEY6898/+ Lsi/+/TorMB07988/+;
hyxEY6898/+
Lsi/+/TorMB07988/+; hyxEY6898/+
Lsi/+;hyxEY6898/+
Figure 1 Geneticinteractionamonglobe/Akt1s1, hyx/CDC73, andTor evidentfromDrosophilaeye phenotypes.Geneticinteractionswererecognizedby theformationof
novelNOGstructures attheventral partoftheadult eye aftercrossesbetween ﬂieswith differentgenotypes.Shownare representativeeye phenotypescapturedby scanning
electron microscopy for w
1118 control (a), heterozygous L
si mutant of lobe/AKT1S1 (b), heterozygous hyx
EY6898 mutant of hyx/CDC73 (c), homozygous Tor
MB07988 mutant of
Tor (d); double heterozygous mutants of lobe and hyx/CDC73 (e), lobe and Tor (f), and hyx/CDC73 and Tor (g); and triple heterozygous hybrid mutants of lobe, hyx/CDC73
and Tor strains (h). Images of additional eyes from triple heterozygous hybrid mutants of lobe, hyx/CDC73 and Tor strains are shown in (j) and (k) (image (i) is a duplicate of
(h)). Higher magniﬁcation images of dysplastic overgrowth regions of (i–k) are shown in (l–n) and (o–q). Higher magniﬁcation images of the ommatidial and sensory bristle
phenotype of the triple heterozygous lobe, hyx/CDC73 and Tor mutant are shown (s and t), with corresponding image of wild-type (r)
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Cell Death and Diseasehad normal levels of Tor transcript (Figure 4b), even though
Tor message levels were successively reduced in hetero-
zygous and homozygous Tor
MB07988 mutant ﬂies (Figure 4b).
TotesttheeffectofMtorinactivationonCdc73expressionin
a mammalianmodel, theexpressionof paraﬁbrominin several
tissues harvested from wild-type and Mtor heterozygous mice
was compared by quantitative immunoblotting. In several
tissues examined, including pancreas, liver, and kidney, the
expression of paraﬁbromin was reduced in Mtor heterozygous
mice relative to b-actin (Supplementary Figure S1).
The translational repressor 4E-BP (eIF4EBP), which
competes with eIF-4G for binding to eIF-4E to regulate
translational initiation,
35 is a downstream target of the Tor
kinase in mammals
28 and in ﬂies.
36 As our results indicate an
interaction between hyx and Tor at the transcriptional level,
welookedforapossibleinteractionbetweenhyxandThor,the
ﬂy ortholog of EIF4EBP. Transcript levels of Thor/EIF4EBP
are reduced by B50% in hyx heterozygotes (hyx
EY6898/þ)
(Figure 4c). This reduction in Thor/EIF4EBP expression was
reversed by the GAL4-induced overexpression of hyx
(Figure 4c). The level of Thor/EIF4EBP transcript in ﬂies
expressing the act5C-Gal4 driver alone was comparable to
the controls (Figure 4d). The level of Thor/EIF4EBP transcript
was reduced by B30% in Tor heterozygotes and additionally
reduced to B50% in double hyx/Tor heterozygotes, a
reduction rescued by overexpression of hyx through the
hyx
EY6898 allele (Figure 4e). Heterozygosity of hyx had no
effect on the expression of S6k, the ﬂy ortholog of RPS6KB1
encoding the ribosomal protein S6 kinase, another well-
characterized downstream target of the Tor kinase in
mammals
37 and in ﬂies
36 (Figure 4f).
Next the effect of starvation on relevant transcript levels in
control and mutant ﬂies was determined (Figures 5a–e).
Although starvation of ﬂies had no effect on Tor transcript
levels (Figure 5a), hyx expression was increased (Figure 5b).
The induction of hyx by starvation persisted in Tor
heterozygotes, suggesting nutritional cues may regulate hyx
transcription independently of Tor activity (Figure 5c). Starva-
tion also increased Thor/EIF4EBP transcript expression
compared with fed controls; however, the level of Thor/
EIF4EBP transcript in starved hyx heterozygous ﬂies was
reduced by B80% compared with starved w
1118 controls
(Figure 5d). There was no difference in the basal Thor/
EIF4EBP transcript level between w
1118 control and Mnn1
heterozygous ﬂies, although the level of starvation-induced
Thor/EIF4EBP was somewhat lower in the Mnn1 mutants
(Figure 5e). These results suggest that the starvation
resistance of both hyx and Tor heterozygous ﬂies results, at
least in part, from impaired upregulation of Thor/EIF4EBP in
response to caloric deprivation.
To look for these interactions in human cellular models, the
effectofserumstarvationontheexpressionofCDC73andthe
three mammalian EIF4EBP isoforms was determined in
HEK293 human embryonic kidney cells and cultured human
peripheral blood mononuclear cells (WBC). Serum starvation
for 48h signiﬁcantly increased CDC73, EIF4EBP1,
EIF4EBP2, and EIF4EBP3 transcript expression in HEK293
cells (Figures 5f–i). In control WBC, as in HEK293 cells,
serum starvation signiﬁcantly increased CDC73 transcript
expression (Supplementary Figure S2).
The expression of EIF4EBP isoforms was compared in
WBC collected from normal healthy volunteer controls and
from patients with the HPT-JT (CDC73 heterozygotes) or
MEN1 (MEN1 heterozygotes) (Supplementary Table S1).
Compared with control WBC, basal levels of all three
EIF4EBP isoforms were reduced in CDC73 heterozygotes
with the most striking reduction in EIF4EBP3 (Figure 6). In
WBC from MEN1 heterozygous patients, the basal level of
EIF4EBP1 transcript was reduced compared with control;
however, there was no difference in the basal EIF4EBP2
level, and basal EIF4EBP3 was increased (Figure 6). Serum
starvation-induced levels of EIF4EBP1 and EIF4EBP2
Table 1 Genetic interactions of L, hyrax,a n dTor
Cross
No. Parent 1 Parent 2 F1 genotype
% ﬂies with
NOG
a eye
phenotype
% NOG in
both
eyes
% notch
w/o OG
Molecular
function
1 w
1118 w
1118 w
1118 00 0
2 L
si/si w
1118 L
si/+ 0 0 100 L (lobe) is the ﬂy homolog of
mammalian AKT1S1 (also
called PRAS40)
3 hyx
EY6898/+ L
si/+;hyx
EY6898/+ 60 1 1 Hyx (hyrax) is the ﬂy homolog
of CDC73/ HRPT2
4 hyx
EY6898/+ w
1118 hyx
EY6898/+ 00 0
5 Tor
MB07988/
MB07988
Tor
MB07988/MB07988 Tor
MB07988/MB07988 00 0 Tor is a key cellular kinase
involved in the regulation of
cell growth and nutritional
homeostasis
6 w
1118 Tor
MB07988/+ 00 0
7 L
si/+ L
si/Tor
MB07988 60 2
8 L
si/+;hyx
EY6898/+ L
si/Tor
MB07988; hyx
EY6898/
+
40*** 7 3
9 hyx
EY6898/+ Tor
MB07988/+; hyx
EY6898/+ 00 0
10 Tor
K17004/+ L
si/+; hyx
EY6898/+ L
si/Tor
K17004; hyx
EY6898/+ 45*** 8 7
11 L
si/Tor
K17004 10 o19
12 hyx
EY6898/+ Tor
K17004/+; hyx
EY6898/+ 00 0
aNOG: notch and overgrowth (OG), with notches and variably sized dysplastic overgrowths in the ventral eye ﬁelds. ***Po0.0001 compared with w1118n, and all
double and single heterozygote mutants
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Cell Death and Diseasetranscript did not discriminate between CDC73 and MEN1
heterozygous patients, and both groups of patients had lower
induced transcript levels than the controls (Figure 6). In
contrast, the serum starvation-induced level of EIF4EBP3
transcript from CDC73 heterozygous patients was markedly
lower than that from both control and MEN1 heterozygous
patient WBCs (Figure 6). Thus, reduced basal and serum
starvation-induced EIF4EBP3 transcript in peripheral WBC
represents a phenotype that correlates strongly with CDC73
heterozygosity, but not with that of MEN1.
Chromatin immunoprecipitation (ChIP) was used in
HEK293 cells to determine if the effect of CDC73 allele
dosage on EIF4EBP3 transcript levels was consistent with
regulation at the transcriptional level. Three pairs of primers
were used to interrogate anti-paraﬁbromin immunoprecipi-
tatesin a ChIP assay by quantitative PCR, with one primer set
(P1) targeting the upstream EIF4EBP3 promoter region,
one set (P2) targeting the internal gene coding sequence at
exon 2, and one set (P3) directed at a ﬂanking region
downstream of the putative poly A signal (Figure 7a).
Antibodies to other components of the PAF1 complex, Leo1,
and Paf1 were also used. As shown in Figure 7b, primer pairs
P1 and P2 produced signiﬁcantly higher signals from the anti-
paraﬁbromin, anti-Leo1, and anti-Paf1 immunoprecipitates
than from those using control IgG. The speciﬁc anti-
paraﬁbromin ChIP signal was much stronger in the P1 and
P2 regions of EIF4EBP3 than in the P3 region, and no signal
at all was detectable in the P3 region with anti-Leo1 or anti-
Paf1 ChIP (Figure 7b). Taken together, these data suggest
that the PAF1 complex might be involved in both EIF4EBP3
transcript initiation and elongation, consistent with PAF1
complex function at other gene loci.
12–14,38
Discussion
Gene expression proﬁling studies of parathyroid tumors by
Haven et al.
39 strongly suggest that sporadic parathyroid
malignancies and tumors associated with CDC73 inactivation
follow a pathway distinct from benign sporadic and MEN1-
related parathyroid tumors. This dichotomy is reinforced by
theclinicalobservationsthatinactivationofCDC73isfrequent
in parathyroid cancer,
8,9 but rare in sporadic benign para-
thyroid tumors,
16,17 whereas mutation of MEN1 is nearly
always associated with benign parathyroid adenomas in both
sporadic and MEN1-associated cases.
We show here that EIF4EBP3 is distinctly regulated by
CDC73 and MEN1, that paraﬁbromin and other PAF1
complex components occupy the EIF4EBP3 promoter and
coding regions, and that loss of EIF4EBP3 expression
represents a marker of CDC73 haploinsufﬁciency and
heterozygosity, but not MEN1 loss-of-function, in a human
WBC model system. As current PCR-based CDC73 germline
mutation testing methods may miss some carriers,
7 our
results indicate it may be possible to independently assess
CDC73 allele dosage by the determination of EIF4EBP3
expression in a clinically practical manner.
The strong evolutionary conservation of the link between
EIF4EBP and CDC73 is striking. Taken together with our
previous ﬁnding that hyx opposes lobe/Akt1S1 in the eye
phenotype assay,
24 the present work strengthens the notion
that TOR and CDC73 interact with an overlapping set of
regulators and effector targets. Functioning as a sensor of
nutrient availability, the protein kinase mTOR regulates cell
growth and autophagy.
26 Under physiological conditions,
growth signals acting through mTOR promote the phospho-
rylation of eIF4EBP and reduce its afﬁnity for eIF-4E; thus
initiating protein synthesis from a pool of transcripts critical for
cell growth and survival. Under pathological conditions, the
enhancedfunctionofeIF-4E,frequentlyaresultofinactivation
of eIF4EBP by mTor phosphorylation, is linked to poor
prognosis and metastasis in multiple malignancies.
30–33
Unlike the inactivation of eIF4EBP by phosphorylation, via
the canonical mTOR pathway, loss of CDC73 exerts its
negative effect on EIF4EBP3 through loss of gene expres-
sion. Our ﬁndings suggest a model in which de-repression of
cap-dependent protein translation and heightened survival
resulting from CDC73 loss-of-function may enhance carcino-
genesis in parathyroid tumors, conferring selectiveadvantage
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Figure 2 Loss of normal apoptosis during pupal development correlates with
the NOG eye phenotype observed in the L/Tor;hyx triple heterozygous mutant ﬂies.
Normal eye development in Drosophila involves a wave of cellular apoptosis
between 35 and 50h after pupal formation (APF) that eliminates a large fraction of
undifferentiated interommatidial cells. The eye discs of L
si/Tor
MB07988 hyx
EY6898/þ
triple heterozygotes with a propensity to later develop the NOG phenotype were
characterized by a substantial reduction in this usual burst of apoptosis APF
compared with w
1118 controls. (a)4 0,6-diamidino-2-phenylindole nuclear staining
(left), TUNEL analysis (middle), and merged images (right) of pupal eye discs
dissected B45h APF reveal a loss and mis-localization of apoptotic-positive
cell nuclei in L
si/Tor
MB07988 hyx
EY6898/þ triple heterozygote ﬂies compared with
w
1118 controls. The difference in size between w
1118 control and L
si/Tor
MB07988
hyx
EY6898/þ triple heterozygote eye discs shown represents a random variation
and was not reﬂective of a consistent difference between the two. (b) Quantiﬁcation
of apoptotic cells per pupal eye disc shows signiﬁcant (B60%) reduction in total
apoptotic-positive cell nuclei in L
si/Tor
MB07988 hyx
EY6898/þ triple heterozygotes
compared with w
1118 controls (***Po0.0001, unpaired Student’s t-test; w
1118
control, n¼16; L
si/Tor
MB07988 hyx
EY6898/þ, n¼18)
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Cell Death and Diseaseto hypermetabolic neoplastic cells for clonal expansion in the
face of nutritional stress.
Materials and Methods
Human subjects. All patients participated in the protocols approved by the
Investigational Review Boards of the National Institute of Diabetes and Digestive
and Kidney Diseases and each gave written consent. Normal volunteers had no
personal or family history of hyperparathyroidism, HPT-JT, or MEN1. Patients with
HPT-JT or MEN1 had documented heterozygous germline mutation of CDC73/
HRPT2 or MEN1, respectively. Patient characteristics are summarized in
Supplementary Table 1.
Fly stocks. The enhancer trapped ﬂy lines from the Japanese NP Consortium
Gal4EnhancerTrapInsertionDatabasewereobtainedfromtheDrosophilaGenetic
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Figure 3 Enhancedstarvationresistance in hyx/CDC73 and Tor mutant ﬂies. Survival upon starvationof the indicatedsingle or double hyx/CDC73 and Tor heterozygous
mutant ﬂy strains is shown. Flies a–g were supplied only with water to test starvationresistance. The number of surviving ﬂies was recorded every 12h. For each experiment,
20 or more vials were used and two or more independent experiments were conducted for each ﬂy line. Vials contained 10 ﬂies each. Each data point represents the pooled
mean survival from 20 to 30 vials of the indicated genotype (*Po0.05; **Po0.001; ***Po0.0001; versus wt for the indicated time points, two–tailed P-values for unpaired
Student’s t-test). The experiment shown in (f) tested the rescue of the starvation resistance of the Tor
K17004/þ; hyx
EY6898/þ double mutant (cf. e) by overexpression of hyx
from the hyx
EY6898 allele upon mating with a driver strain expressing GAL4 from the 5C-actin promoter (act-GAL4), with the driver-only control shown (act-GAL4/þ; dashed
gray line). In panel f, the P values for the unpaired Student’s t-test comparing the % survival of w
1118 control strain with the act-Gal4/Tor
K17004/þ; hyx
EY6898/þ strain were:
84h, P¼0.32; 96h, P¼0.14; 108h, P¼0.036
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Cell Death and DiseaseResource Center, Kyoto Institute of Technology (Kyoto, Japan). The ﬂy line bearing
the hypomorphic allele, hyx
EY6898, which contains a P-element (P[EPgy2]) insertion
located 36bp upstream of the hyx translational start site in the 50 untranslated
transcript region (Stock No. 16768), and all the other ﬂy lines used, including
Mnn1
DG30701 (Stock No. 21335), Tor
K17004/CyO (Stock No. 11218), Tor
MB07988
(Stock No. 25363), and Act5C-GAL4/CyO (Stock no. 4414), were from the
BloomingtonDrosophilaStockCenterat IndianaUniversity(Bloomington,IN,USA).
Scanning electron microscopy. Flies were ﬁxed in 4% paraformaldehyde
(Electron Microscopy Sciences, Hatﬁeld, PA, USA). Before examination, the
samples were dehydrated through 100% ethanol, and then critically point dried
(Tousimis model Samdri-795, Rockville, MD, USA). A 10-nm gold coating was
depositedinasputtercoater(ElectronMicroscopySciencesmodel575 ),andthe
detailed structure of the ﬂy eyes were studied at 5kV on a scanning electron
microscope (Hitachi S-3400N, Pleasanton, CA, USA).
Pupal eye disc apoptosis analysis. The ApopTag Red In situ Apoptosis
DetectionKit(Millipore,Billerica,MA,USA)wasusedforTUNELanalysis.Eyediscs
collected B45h following pupation were dissected in PBS and analyzed for
apoptosis following the same method as previously described for the eye discs of
third instar ﬂy larvae.
24
Fly starvation resistance. For starvation stress tests, ﬂies with desired
genotypes that eclosed within 24h were collected. After ageing for 8 days at 251C,
mated female ﬂies were placed into vials containing paper discs (d¼2.3cm)
soaked in 400mlo fH 2O (Whatman, Piscataway, NJ, USA). H2O was replenished
throughout the experiment as needed. A total of 20–30 vials (10 ﬂies per vial) were
usedforeachtest,andatleasttwoindependentexperimentswereperformed.Dead
ﬂies were recorded every 12h. For data analysis, each vial was treated as a data
point.
mRNAquantiﬁcation. Geneexpressionlevelswereestimatedonthebasisof
the transcript abundance as measured by quantitative RT-PCR. Quantitative
RT-PCR was performed with one-step quantitative RT-PCR master mix (Agilent
Technologies, Santa Clara, CA, USA) using a Stratagene MX 3005P real time PCR
machine (Agilent Technologies) and analyzed using the accompanying software.
Each reaction was conducted in triplicate and three to nine biological samples
prepared independently were used in data analysis. The Prism software version
5.0c (GraphPad Software, Inc., La Jolla, CA, USA) was used for graphing the
analyzed data set. Total RNA was prepared from both mutant and control samples
usingQIAGENRNeasykit(Valencia,CA,USA).Primer sequencesweredeveloped
using PrimerQuest software (Integrated DNA Technologies, Coralville, IA, USA),
and were as follows: Drosophila Tor forward (50-TGG CAA AGC AAC TGG GCA
AGA A-30) and reverse (50-TCG GGA TCC ACA ATG CGA TGT T-30); hyx forward
(50-TTT GCG TGC CAT CCT GGA CTA T-30) and reverse (50-TCT TGC CCG TGC
TTT GCA GAA T-30); Mnn1 forward (50-CAA ATG GAT AGA CGG ACT GCT CGT-
30) and reverse (50GTC AAC AGT TCG TAA CAA GGA TTT GC-30); Thor forward
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Figure 4 Transcriptional regulation of Tor, hyx, and Thor in ﬂy. Heterozygous Tor
þ/  (Tor
MB07988/þ) and homozygous Tor
 /  (Tor
MB07988/MB07988) mutant ﬂies have a
dose-dependentreductioninbothTorandhyxtranscriptcomparedwithw
1118controls(aandb).Heterozygoushyx(hyx
EY6898/þ)mutantﬂiesshowareductioninhyx,butnot
in Tor transcript expression (a and b). Thor/4E-BP transcript expression is signiﬁcantly reduced in hyx/CDC73
þ/  ﬂies compared with w
1118 controls, and is rescued back to
control levels following act5C-GAL4-driven overexpression of hyx/CDC73 from the hyx
EY6898 allele (c). The act5C-GAL4/þ driver alone has no effect on Thor/4E-BP
transcriptlevels(d).Tor
þ/ heterozygosityandTor
þ/ ;hyx
þ/ doubleheterozygosityresultsinadecreaseinThor/4E-BPtranscriptlevels,andissimilarlyrescuedfollowing
act5C-GAL4-driven overexpression of hyx/CDC73 from the hyx
EY6898 allele in the Tor
þ/ ;hyx
þ/  double heterozygous mutant background (e). Heterozygosity of hyx/
CDC73
þ/  has no effect on transcript levels of s6k/RPS6KB1, which is, like 4E-BP, a major effector of Tor (f). For a, b, c, and e **Po0.005; ***Po0.0005 compared with
w
1118 control, using unpaired Student’s t-test
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Cell Death and Disease(50-CCA TGA TCA CCA GGAAGGTTGTCA-30) and reverse (50-TCT TCA TGA AAG
CCC GCT CGT AGA-30); s6k forward (50-ATG CGG CGG CTG TTC AAA TAC A-30)
and reverse (50-TGG CAC TTT CGC TTA GCG TTG T-30). Human CDC73 forward
(50-AGA TGC AAC CAG GGG GCA CTG-30) and reverse (50-GCA GGA CCC TGC
ACA AAA ACG G-30); EIF4EBP1 forward (50-TGG ACA AGA ACG AAC CCT TCC
T-30) and reverse (50-AGG GAG CTT TCC CAA GCA CAT-30); EIF4EBP2 forward
(50-TTT GCA TTC ACC CTC CTT CCC A-30) and reverse (50-AGG GCA CCA AAT
CCA ACC AGA A-30); EIF4EBP3 forward (50-AAG TTC CTG CTG GAG TGC AAG
A-30) and reverse (50-TCT CCT GCT CCT TCA GCT CCT C-30).
Immunoblotting and infrared imaging. Tissues from 6-week old female
wild-type C57BL/6 and Mtor heterozygous mice (Jackson Laboratory, Bar Harbor,
ME, USA, strain B6.129S5-MtorMtor
Gt(OST92090)Lex/J, Stock No. 013190) were
stored at  801 and then thawed on ice. For every 50mg of mouse tissue, 1ml of
1  RIPA cell lysis buffer (Cell Signaling, Beverly, MA, USA, Cat. No. 9806)
including 1  protease inhibitors (Calbiochem, EMD Serono, Inc., Rockland, MA,
USA, Cat. No. 539134) was added followed by homogenization on ice in a 1.5-ml
microcentrifuge tube using a tissue homogenizer (Omni International, Kennesaw,
GA,USA,ModelTH-115)at highspeedfor 30s.Homogenates werecombinedwith
an equalvolume of Laemmli’s2  gel loadingbuffer, vortexed,and heatedat 951C
for 10min before gel loading. Electrophoresis by SDS-PAGE was followed by the
transfer of the proteins on to 0.45-micron nitrocellulose membrane. Membranes
were blocked with TBS or PBS (pH 7.4) containing 0.1% Tween 20 and 5% nonfat
dry milk (blocking buffer), and incubated overnight with primary antibodies in the
same buffer. Primary antibodies used were rabbit anti-paraﬁbromin polyclonal
(GRAPEantibody
40) and mouse monoclonal anti-b- actin (Sigma-Aldrich, St. Louis,
MO, USA, Cat. No. A5316). Membranes were then washed, and IR-labeled
secondaryantibodies(dilution1:20000)wereusedfordetectingtheproteinsignals
in conjunction with the Odyssey infrared imaging system (LI-COR Biosciences,
Lincoln,NE,USA). Quantiﬁcation of paraﬁbrominimmunoreactivityusedtheb-actin
signal in the same lane for normalization. IR secondary antibodies (anti-rabbit IR
800 and anti-mouse Green) were from LI-COR Biosciences.
Mammalian cell culture. Human embryonic kidney HEK293 cells (American
Type Culture Collection, Manassas, VA, USA, Cat. No. CRL-1573) were grown in
75-cm
2 ﬂasks in DMEM supplemented with 10% fetal bovine serum (FBS), 4mML-
glutamine and penicillin/streptomycin at 371C and 5% CO2. For serum-starvation
experiments, HEK293 cells newly seeded the night before were either fed with
medium supplemented with 10% FBS (control) or not (starved) for 48h. Cells were
then detached using Trypsin–EDTA, pelleted in microcentrifuge tubes, and either
used immediately or stored at  801C.
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Figure 5 Transcriptional regulation of hyx/CDC73 and Thor/4E-BP in response to caloric or serum starvation. Upregulation in w
1118 control or mutant ﬂies of hyx/CDC73
and Thor/4E-BP, but not of Tor transcript, compared with fed controls following 48h of starvation (a–d). The basal reduction of hyx transcript observed in Tor
þ/  (Tor
MB0798/þ)
heterozygous ﬂies was lost following 48h of starvation, suggesting that nutritional cues may regulate hyx transcription independently of Tor activity (c). Conversely, the basal
reduction in Thor/4E-BP transcript observed in hyx
þ/  heterozygous ﬂies persists following 48h of starvation, suggesting that hyx is necessary for the starvation-induced
increase in Thor/4E-BP transcript (d). Basal expression of Thor/4E-BP transcript was unchanged in Mnn1
þ/  (Mnn1
DG30701/þ) heterozygous ﬂies compared with w
1118
controls; however, the level of Thor transcript was somewhat reduced following 48h of starvation (e). Expression of human CDC73, EIF4EBP1, EIF4EBP2, and EIF4EBP3
transcript was signiﬁcantly increased in HEK293 cells following 48h of serum starvation (f–i). For b–i *Po0.05, **Po0.005; ***Po0.0005 compared with control, using
unpaired Student’s t-test
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Cell Death and DiseaseAmononuclear cellfractionwasisolatedfromamorningwholebloodsampledrawn
fromnon-fastingnormal volunteers,CDC73or MEN1 heterozygotes (collectedat room
temperature in heparinized tubes) processed using Lymphocyte Separation Medium
(Lonza, Walkersville, MD, USA, Cat. No. 17–829E). The buffy layer, enriched in
lymphocytes and mononuclear cells, was collected, washed once in PBS after which
the cells were resuspended in complete RPMI medium 1640 (GIBCO, Life
Technologies, Grand Island, NY, USA) containing 10% FBS, plated on to 12-well
cell culture plates and incubated at 371C with 5% CO2. After 24h of incubation, non-
adherent cells were gently removed and the adherent cell population, enriched in
mononuclear cells, was divided and further incubated with either fresh complete RPMI
medium (control cells) or the RPMI medium without serum (serum-starved cells) foran
additional 72h. The cells were then detached by trypsin–EDTA treatment, pelleted in
microcentrifuge tubes, and stored at  801C until use.
ChIP assay. ChIP assay kit from Millipore (Cat. No. 17–295) was used in the
analysis of HEK293 cells following the manufacturer’s instructions except that the
QIAquick PCR puriﬁcation kit (Qiagen, Cat. No. 28104) was used for DNA
puriﬁcation. Puriﬁed DNA was used as a template for the ampliﬁcation of selected
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Figure6 HeterozygosityofCDC73resultsinareductionofEIF4EBPtranscriptlevelsinhumanWBCs.WBCswerecollectedfromhealthyvolunteersorfrompatientswith
HPT-JT(CDC73heterozygotes)orMEN1(MEN1heterozygotes).TheexpressionoftranscriptsfortheindicatedisoformsofEIF4EBPwasdeterminedbyquantitativeRT-PCR
following 72h of control culture conditions or serum starvation, as indicated. The same data are presented as scatter dot plots on the left (a, c and e) and histograms on the
right (b, d and f). Control, n¼43–62 transcript measurements from eight cell harvests from eight normal volunteers. CDC73
þ/ , n¼22–34 transcript measurements from
sevencell harvestsfromﬁve patients.MEN1
þ/ , n¼37–47transcript measurements from11 cell harvestsfrom 9 patients.For a–f *Po0.05, **Po0.005;***Po0.0005 for
indicated comparisons, using unpaired Student’s t-test
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Cell Death and Diseaseregions of EIF4EBP3 and its ﬂanking sequences using the following primer pairs
(Figure 7a): P1 (upstream promoter region, PCR product 191bp, forward 50-TCC
CTTCCT GCAAGA TGT GTG ACT-30, reverse 50-TGG CCC AGC GCTGGCCAA
CCT GCC-30); P2 (exon 2 region, PCR product 206bp, forward 50-TCC TGA CTC
TTACCTCAGTCCCAA-30,reverse50-TACCGGGTATCTCTTCCTCTGTCT-30);
P3 (downstream region following putative polyA signal, PCR product 288bp, forward
50-TCTCATCTCAGCCACACAGCTGAA-30,reverse50-ATAGGCTGGGACAGC
ACC TCT T-30). Antibodies used for the ChIP assay were anti-paraﬁbromin (GRAPE
antibody
40), anti-Leo1 (Bethyl Laboratories, Montgomery, TX, USA, Cat. No. A300-
175A) and anti-Paf1 (Upstate (Millipore), Cat. No. 07–653), and control rabbit IgG
(Santa Cruz Biotechnologies, Santa Cruz, CA, USA, Cat. No. sc-2027). Real-time
quantitative PCR was performed using 2  Brilliant II SYBR green QPCR master mix
(Agilent Technologies, Cat. No. 600828-51) using the Stratagene Mx3005P QPCR
system.PCR parameters used were 951C 10min, 40 cycles of 941C3 0s ,6 0 1C1m in ,
and721C1min,followedby 1cycleofdissociationcurveanalysis.Thesizeand quality
of the PCR-ampliﬁed DNA was assessed by agarose gelelectrophoresis and ethidium
bromide staining in comparison to DNA markers (GeneRuler DNA Ladder Mix,
Fermentas, Glen Burnie, MD, USA, Cat. No. SM0333). Data analysis and graphing
were performed using Prism software version 5.0c (GraphPad Software, Inc.) with
results expressed as percentage input signal after normalizing Ct values from each
primer set.
Statistical analysis. Data were analyzed by Prism software version 5.0c.
(GraphPad Software, Inc.). Unpaired Student’s t-test was used to evaluate for
statistical signiﬁcance.
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Figure 7 ChIP demonstrates occupancy at EIF4EBP3 by the PAF1 complex.
The physical association of endogenous paraﬁbromin and other components of the
PAF1 complex (including the Paf1 and Leo1 proteins) with human EIF4EBP3 was
examined by ChIP in HEK293 cells. (a) Schematic diagram showing the relative
locationofthethreePCRprimersetsusedintheChIPassay(P1,P2,andP3)along
the human EIF4EBP3 gene (HGNC ID: 3290) and ﬂanking regions (not to scale).
The numbering shown is relative to the ﬁrst base of exon 1 as þ1 as indicated.
(b) ChIP analysis using primer sets targeting upstream (P1), exon 2 (P2) and
downstream (P3) sequence of EIF4EBP3 using antibodies against paraﬁbromin,
Leo1 or Paf11 or control rabbit IgG as shown. Results shown are mean percentage
of input signal±S.E.M. (c) Qualitativeanalysis of ChIP PCR-derived DNA products
by agarose gel electrophoresis and ethidium bromide staining. All experiments are
representative of three or more independent biological repeats
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